Addison Whitney conducts market research for name and logo of Sanofi Pasteur's upcoming vaccine, Pentacel
CHARLOTTE, NORTH CAROLINA, May 30, 2007 -Addison Whitney was pleased to conduct the market research on both the name and logo validation of Sanofi Pasteur's upcoming combination vaccine referred to as Pentacel. The brand consulting firm provided additional regulatory expertise through their assistance in developing the regulatory FDA submission documents.For more information, please call Lizzy Guterma at 704-697-4055 or lizzy.guterma@addisonwhitney.com or visit www.addisonwhitney.com.
About Addison Whitney
Addison Whitney is a global full-service brand consulting firm. Founded in 1991, the firm has extended its services to offer branding expertise in the areas of verbal branding, visual branding, brand strategy, and research and analysis. Clients come to Addison Whitney from industries including: consumer, technology, business to business and other market segments. Addison Whitney health, a specialized healthcare division of Addison Whitney, serves the branding needs of pharmaceutical, biotechnology, life science, and medical specialties. For more information, visit www.addisonwhitney.com.
« BACK TO PRESS RELEASES
